Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — NEW ORLEANS — Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, increasing its prospects as an investigational neuroprotective therapy. In patients with relatively…
:max_bytes(150000):strip_icc()/Health-GettyImages-2192598199-8dc33d726aa64a739a649cac43b5b740.jpg?w=390&resize=390,220&ssl=1 "How the AIP Diet Can Lower Inflammation and Improve Your Well-Being")
